Ton J. Rabelink mainly focuses on Internal medicine, Endocrinology, Endothelium, Nitric oxide and Endothelial dysfunction. His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus, Type 2 diabetes and Cardiology. His research investigates the link between Endocrinology and topics such as CTGF that cross with problems in Fibrosis.
His Endothelium research includes elements of Endothelial stem cell and Inflammation, Immunology, Cell adhesion molecule, Monocyte. His Nitric oxide study incorporates themes from Oxidative stress, Biochemistry, In vivo and Endothelin receptor. Ton J. Rabelink has included themes like Flow-Mediated Vasodilation, Angiotensin-converting enzyme, ACE inhibitor, Omega-N-Methylarginine and Angiotensin II in his Endothelial dysfunction study.
His primary scientific interests are in Internal medicine, Endocrinology, Immunology, Endothelium and Kidney. His research investigates the connection with Internal medicine and areas like Cardiology which intersect with concerns in Asymptomatic. His works in Nitric oxide, Insulin resistance, Vasodilation, Postprandial and Blood pressure are all subjects of inquiry into Endocrinology.
Ton J. Rabelink has researched Nitric oxide in several fields, including Biochemistry and Superoxide. His research in Endothelium intersects with topics in Endothelial stem cell, Inflammation, Vascular disease and Cell biology. Ton J. Rabelink combines subjects such as Transplantation and Pathology with his study of Kidney.
The scientist’s investigation covers issues in Internal medicine, Cell biology, Kidney, Immunology and Neutrophil extracellular traps. His Internal medicine research is multidisciplinary, incorporating elements of Diabetes mellitus, Endocrinology and Gastroenterology. In his study, which falls under the umbrella issue of Endocrinology, Podocyte is strongly linked to Heparanase.
His studies deal with areas such as Endothelial stem cell, Endothelium and Induced pluripotent stem cell as well as Cell biology. The Kidney study combines topics in areas such as Pathology, Stromal cell, Mesenchymal stem cell, Cancer research and Transplantation. He has researched Neutrophil extracellular traps in several fields, including ANCA-Associated Vasculitis, Myeloperoxidase and Pathogenesis.
Ton J. Rabelink focuses on Internal medicine, Kidney, Cell biology, Immunology and Diabetic nephropathy. His Internal medicine study typically links adjacent topics like Endocrinology. His studies in Endocrinology integrate themes in fields like Outpatient clinic and Lumbar vertebrae.
His Kidney research includes themes of Cancer research, microRNA, Vascular endothelial growth factor and Pathology. His Cell biology study combines topics in areas such as Endothelial stem cell, Transcriptome, Angiogenesis and Protein Quaking. His Diabetic nephropathy research incorporates elements of Heparanase, Glomerulosclerosis, Albuminuria and Glycocalyx.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endothelial Function and Dysfunction Testing and Clinical Relevance
John E. Deanfield;Julian P. Halcox;Ton J. Rabelink.
Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes
Cindy J.M. Loomans;Eelco J.P. de Koning;Frank J.T. Staal;Maarten B. Rookmaaker.
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz.
The New England Journal of Medicine (2011)
Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.
E Stroes;J Kastelein;F Cosentino;W Erkelens.
Journal of Clinical Investigation (1997)
Expression of connective tissue growth factor in human renal fibrosis
Yasuhiko Ito;Jan Aten;Richard J. Bende;Barry S. Oemar.
Kidney International (1998)
Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial
Liesbeth Bax;Arend-Jan J. Woittiez;Hans J. Kouwenberg;Willem P. T. M. Mali.
Annals of Internal Medicine (2009)
Cellular regulation of endothelial nitric oxide synthase.
Roland Govers;Ton J. Rabelink.
American Journal of Physiology-renal Physiology (2001)
Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.
E.S.G. Stroes;H.A. Koomans;T.J. Rabelink;T.W.A. de Bruin.
The Lancet (1995)
Endothelin-A Receptor Antagonist–Mediated Vasodilatation Is Attenuated by Inhibition of Nitric Oxide Synthesis and by Endothelin-B Receptor Blockade
Marianne C. Verhaar;Fiona E. Strachan;David E. Newby;Nicholas L. Cruden.
The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data
Victor J. Dzau;Kenneth Bernstein;David Celermajer;Jerome Cohen;Jerome Cohen.
American Journal of Cardiology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: